Molecular neurobiology and genetics: Investigation of neural function and dysfunction

Neuron

Volumn 20, Issue 3, 1998, Pages 427-444

  Green, Tim ^b   Heinemann, Stephen F ^b   Gusella, Jim F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CHOLINERGIC RECEPTOR; GLUTAMATE RECEPTOR; GLYCINE RECEPTOR; ION CHANNEL; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; CHANNEL GATING; GENE MAPPING; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0032032015     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80986-1     Document Type: Review

References (176)

1. Akabas, M.H., and Karlin, A. (1995). Identification of acetylcholine receptor channel-lining residues in the M1 segment of the α-subunit. Biochemistry 34, 12496-12500.
2. Akabas, M.H., Stauffer, D.A., Xu, M., and Karlin, A. (1992). Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 258, 307-310.
3. Akabas, M.H., Kaufmann, C., Archdeacon, P., and Karlin, A. (1994). Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the α subunit. Neuron 13, 919-927.
4. Andrade, M.A., and Bork, P. (1995). HEAT repeats in the Huntington's disease protein. Nature Genet. 11, 115-116.
5. Antz, C., Geyer, M., Fakler, B., Schott, M.K., Guy, H.R., Frank, R., Ruppersberg, J.P., and Kalbitzer, H.R. (1997). NMR structure of inactivation gates from mammalian voltage-dependent potassium channel. Nature 385, 272-275.
6. Armstrong, C.M., and Hille, B. (1998). Voltage-gated ion channels and electrical excitability. Neuron 20, this issue, 371-380.
7. Ballivet, M., Patrick, J., Lee, J., and Heinemann, S. (1982). Molecular cloning of cDNA coding for the γ subunit of Torpedo acetylcholine receptor. Proc. Natl. Acad. Sci. USA 79, 4466-4470.
8. Bannon, A.W., Decker, M.W., Holladay, M.W., Curzon, P., Donnelly-Roberts, D., Puttfarcken, P.S., Bitner, R.S., Daiz, A., Dickenson, A.H., Porsolt, R.D., et al. (1998). Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279, 77-81.
9. Bates, G.P., Valdes, J., Hummerich, H., Baxendale, S., Le Paslier, D.L., Monaco, A.P., Tagle, D., MacDonald, M.E., Altherr, M., Ross, M., et al. (1992). Characterization of a yeast artificial chromosome contig spanning the Huntington's disease gene candidate region. Nature Genet. 1, 180-187.
10. Baxendale, S., MacDonald, M.E., Mott, R., Francis, F., Lin, C., Kirby, S.F., James, M., Zehetner, G., Hummerich, H., Valdes, J., et al. (1993). A cosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. Nature Genet. 4, 181-186.
11. Beck, C., Moulard, B., Steinlein, O., Guipponi, M., Vallee, L., Montpied, P., Baldy-Moulnier, M., and Malafosse, A. (1994). A nonsense mutation in the alpha4 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBNI). Neurobiol. Dis. 1, 95-99.
12. Bennett, J.A., and Dingledine, R. (1995). Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining re-entrant membrane loop. Neuron 14, 373-384.
13. Biervert, C., Schroeder, B.C., Kubisch, C., Berkovic, S.F., Propping, P., Jentsch, T.J., and Steinlein, O.K. (1998). A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406.
14. Bliss, T.V., and Collingridge, G.L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
15. 3 receptor. J. Neurochem. 64, 1401-1405.
16. Bormann, J., Hamill, O.P., and Sakmann, B. (1987). Mechanism of anion permeation through channels gated by glycine and γ-aminobutyric acid in mouse cultured spinal neurons. J. Physiol. 385, 243-286.
17. Boulter, J., Evans, K., Goldman, D., Martin, G., Treco, D., Heinemann, S., and Patrick, J. (1986). Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor α-subunit. Nature 319, 368-374.
18. Brake, A.J., Wagenbach, M.J., and Julius, D. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371, 519-523.
19. Brooks, B.P., and Fischbeck, K.H. (1995). Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci. 18, 459-461.
20. Brose, N., Gasic, G.P., Vetter, D.E., Sullivan, J.M., and Heinemann, S.F. (1993). Protein chemical characterization and immunological localization of the NMDA receptor subunit NMDA R1. J. Biol. Chem. 268, 22663-22671.
21. Brune, W., Weber, R.G., Saul, B., von Knebel Doeberitz, M., Grond-Ginsbach, C., Kellerman, K., Meinck, H.M., and Becker, C.M. (1996). A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors. Am. J. Hum. Genet. 58, 989-997.
22. Brusa, R., Zimmermann, F., Koh, D.-S., Feldmeyer, D., Gass, P., Sakmann, B., Seeburg, P.H., and Sprengel, R. (1995). Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270, 1677-1680.
23. Buckwalter, M.S., Cook, S.A., Davisson, M.T., White, W.F., and Camper, S.A. (1994). A frameshift mutation in the mouse alpha1 glycine receptor gene (Glra1) results in progressive neurological symptoms and juvenile death. Hum. Mol. Genet. 3, 2025-2030.
24. A receptor affecting modulation of the channel by ligands of the benzodiazepine binding-site. Mol. Pharmacol. 49, 1080-1084.
25. Bulman, D.E. (1997). Phenotypic variation and newcomers in ion channel disorders. Hum. Mol. Genet. 6, 1679-1685.
26. Burns, C.M., Chu, H., Rueter, S.M., Hutchinson, L.K., Canton, H., Sanders-Bush, E., and Emeson, R.B. (1997). Regulation of serotonin 2C receptor G protein coupling by RNA editing. Nature 387, 303-308.
27. Changeux, J.-P., Galzi, J.L., Devillers-Thiery, A., and Bertrand, D. (1992). The functional architecture of the acetylcholine nicotinic receptor explored by affinity labelling and site-directed mutagenesis. Quart. Rev. Biophys. 25, 395-432.
28. Choi, D.W. (1994). Calcium and excitotoxic neuronal injury. Ann. N. Y. Acad. Sci. 747, 162-171.
29. Claudio, T., Ballivet, M., Patrick, J., and Heinemann, S. (1983). Nucleotide and deduced amino acid sequences of Torpedo californica acetylcholine receptor γ subunit. Proc. Natl. Acad. Sci. USA 80, 1111-1115.
30. Collins, F.S. (1990). Identifying human disease genes by positional cloning. Harvey Lect. 86, 149-164.
31. Cooper, E., Couturier, S., and Ballivet, M. (1991). Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350, 235-238.
32. Couturier, S., Bertrand, D., Matter, J.-M., Hernandez, M.-C., Bertrand, S., Millar, N., Valera, S., Barkas, T., and Ballivet, M. (1990). A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron 5, 847-856.
33. Croxen, R., Newland, C., Beeson, D., Oosterhuis, H., Chauplannaz, G., Vincent, A., and Newsom-Davis, J. (1997). Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 6, 767-774.
34. Culiat, C.T., Stubbs, L.J., Woychik, R.P., Russell, L.B., Johnson, D.K., and Rinchik, E.M. (1995). Deficiency of the beta3 subunit of the type A gamma-aminobutyric acid receptor causes cleft palate in mice. Nature Genet. 11, 344-346.
35. Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L., and Bates, G.P. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
36. Davies, S.W., Beardsall, K., Turmaine, M., DiFiglia, M., Aronin, N., and Bates, G.P. (1998). Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 351, 131-133.
37. Devillers-Thiery, A., Changeux, J.-P., Paroutaud, P., and Strosberg, A.D. (1979). The amino-terminal sequence of the 40,000 molecular weight subunit of the acetylcholine receptor protein from Torpedo marmorata. FEBS Lett. 104, 99-105.
38. Devillers-Thiery, A., Giraudat, J., Bentaboulet, M., and Changeux, J.-P. (1983). Complete mRNA coding sequence of the acetylcholine binding α-subunit of Torpedo marmorata acetylcholine receptor: a model for the transmembrane organization of the polypeptide chain. Proc. Natl. Acad. Sci. USA 80, 2067-2071.
39. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P., and Aronin, N. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
40. Dong, H., O'Brien, R.J., Fung, E.T., Lanahan, A.A., Worley, P.F., and Huganir, R.L. (1997). GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386, 279-284.
41. Dunn, S.M.J., Conti-Tronconi, B.M., and Raftery, M.A. (1993). A high-affinity site for acetylcholine occurs close to the α-γ subunit interface of the Torpedo nicotinic acetylcholine receptor. Biochemistry 32, 8616-8621.
42. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.P., Gusella, J.F., Joyner, A.L., et al. (1995). Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269, 407-410.
43. Ebralidz, A.K., Rossi, D.J., Tonegawa, S., and Slater, N.T. (1996). Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene. J. Neurosci. 16, 5014-5025.
44. Egebjerg, J., Kukekov, V., and Heinemann, S.F. (1994). Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence. Proc. Natl. Acad. Sci. USA 91, 10270-10274.
45. Elgoyhen, A.B., Johnson, D.S., Boulter, J., Vetter, D.E., and Heinemann, S. (1994). α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79, 705-715.
46. Elmslie, F.V., Hutchings, S.M., Spencer, V., Curtis, A., Covanis, T., Gardiner, R.M., and Rees, M. (1996). Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis. J. Med. Genet. 33, 435-436.
47. Engel, A.G., Ohno, K., Bouzat, C., Sine, S.M., and Griggs, R.C. (1996a). End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit. Ann. Neurol. 40, 810-817.
48. Engel, A.G., Ohno, K., Milone, M., Wang, H.L., Nakano, S., Bouzat, C., Pruitt, J.N., Hutchinson, D.O., Brengman, J.M., Bren, N., et al. (1996b). New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 5, 1217-1227.
49. Ferrer-Montiel, A.V., and Montal, M. (1996). Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc. Natl. Acad. Sci. USA 93, 2741-2744.
50. Finer-Moore, J., and Stroud, R.M. (1984). Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. Proc. Natl. Acad. Sci. USA 81, 155-159.
51. Fontaine, B., Khurana, T.S., Hoffman, E.P., Bruns, G.A., Haines, J.L., Trofatter, J.A., Hanson, M.P., Rich, J., McFarlane, H., Yasek, D.M., et al. (1990). Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 250, 1000-1002.
52. Forman, S.A., Yellen, G., and Thiele, E.A. (1996). Alternative mechanism for pathogenesis of an inherited epilepsy by a nicotinic AChR mutation. Nature Genet. 13, 396-397.
53. Goate, A.M. (1997). Molecular genetics of Alzheimer's disease. Geriatrics 52 (suppl.), S9-S12.
54. Gomez, C.M., and Gammack, J.T. (1995). A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 45, 982-985.
55. Gomez, C.M., Maselli, R., Gammack, J., Lasalde, J., Tamamizu, S., Cornblath, D.R., Lehar, M., McNamee, M., and Kuncl, R.W. (1996). A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome. Ann. Neurol. 39, 712-723.
56. Görne-Tschlenokow, U., Strecker, A., Kaduk, C., Naumann, D., and Hucho, F. (1994). The transmembrane domains of the nicotinic acetylcholine receptor contain α-helical and β structures. EMBO J. 13, 338-341.
57. Greenblatt, R.E., Blatt, Y., and Montal, M. (1985). The structure of the voltage-sensitive sodium channel. FEBS Lett. 193, 125-134.
58. Gusella, J.F. (1986). DNA polymorphism and human disease. Annu. Rev. Biochem. 55, 831-54.
59. Gusella, J.F. (1989). Location cloning strategy for characterizing genetic defects in Huntington's disease and Alzheimer's disease. FASEB J. 3, 2036-2041.
60. Gusella, J.F., and MacDonald, M.E. (1993). Hunting for Huntington's disease. Mol. Genet. Med. 3, 139-158.
61. Gusella, J.F., Wexler, N.S., Conneally, P.M., Naylor, S.L., Anderson, M.A., Tanzi, R.E., Watkins, P.C., Ottina, K., Wallace, M.R., Sakaguchi, A.Y., et al. (1983). A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306, 234-238.
62. Gusella, J.F., Tanzi, R.E., Anderson, M.A., Hobbs, W., Gibbons, K., Raschtchian, R., Gilliam, T.C., Wallace, M.R., Wexler, N.S., and Conneally, P.M. (1984). DNA markers for nervous system diseases. Science 225, 1320-1326.
63. Gusella, J.F., MacDonald, M.E., Ambrose, C.M., and Duyao, M.P. (1993). Molecular genetics of Huntington's disease. Arch. Neurol. 50, 1157-1163.
64. Gusella, J.F., and MacDonald, M.E. (1995). Huntington's disease: CAG genetics expands neurobiology. Curr. Opin. Neurobiol. 5, 656-662.
65. Gusella, J.F., Persichetti, F., and MacDonald, M.E. (1997). The genetic defect causing Huntington's disease: repeated in other contexts? Mol. Med. 3, 238-246.
66. Guy, H.R., and Seetharamulu, P. (1986). Molecular model of the action potential sodium channel. Proc. Natl. Acad. Sci. USA 83, 508-512.
67. Guy, H.R., and Conti, F. (1990). Pursuing the structure and function of voltage-gated channels. Trends Neurosci. 13, 201-206.
68. Higuchi, M., Single, F.N., Köhler, M., Sommer, B., Sprengel, R., and Seeburg, P.H. (1993). RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75, 1361-1370.
69. Hollmann, M., and Heinemann, S. (1994). Cloned glutamate receptors. Ann. Rev. Neurosci. 17, 31-108.
70. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252, 851-853.
71. Hollmann, M., Maron, C., and Heinemann, S. (1994). N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron 13, 1331-1343.
72. Hollmann, M., O'Shea-Greenfield, A., Rogers, S.W., and Heinemann, S. (1989). Cloning by functional expression of a member of the glutamate receptor family. Nature 342, 643-648.
73. Hume, R.I., Dingledine, R., and Heinemann, S. (1991). Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 253, 1028-1031.
74. Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
75. Hutton, M., and Hardy, J. (1997). The presenilins and Alzheimer's disease. Hum. Mol. Genet. 6, 1639-1646.
76. Imoto, K., Methfessel, C., Sakmann, B., Mishina, M., Mori, Y., Konno, T., Fukuda, K., Kurasaki, M., Bujo, H., Fujita, Y., and Numa, S. (1986). Location of a δ-subunit region determining ion transport through the acetylcholine receptor channel. Nature 324, 670-674.
77. Imoto, K., Busch, C., Sakmann, B., Mishina, M., Konno, T., Nakai, J., Bujo, H., Mori, Y., Fukuda, K., and Numa, S. (1988). Rings of negatively charged amino-acids determine the acetylcholine-receptor channel conductance. Nature 335, 645-648.
78. Jia, Z., Agopyan, N., Miu, P., Xiong, Z., Henderson, J., Gerlai, R., Taverna, F.A., Velumian, A., MacDonald, J., Carlen, P., et al. (1996). Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17, 945-956.
79. Karlin, A., and Akabas, M.H. (1995). Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15, 1231-1244.
80. Kashiwabuchi, N., Ikeda, K., Araki, K., Hirano, T., Shibuki, K., Takayama, C., Inoue, Y., Kutsuwada, T., Yagi, T., Kang, Y., et al. (1995). Impairment of motor coordination, Purkinje cell synapse formation, and cerebellar long-term depression in GluRδ2 mutant mice. Cell 81, 245-252.
81. B receptors uncovers similarity to metabotropic glutamate receptors. Nature 386, 239-246.
82. Kennedy, M.B. (1997). The postsynaptic density at glutamatergic synapses. Trends Neurosci. 20, 264-268.
83. Kim, T.W., and Tanzi, R.E. (1997). Presenilins and Alzheimer's disease. Curr. Opin. Neurobiol. 7, 683-688.
84. 2, an ATP-gated ion channel. Biochem. Biophys. Res. Comm. 240, 618-622.
85. Kingsmore, S.F., Giros, B., Suh, D., Bieniarz, M., Caron, M.G., and Seldin, M.F. (1994). Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nature Genet. 7, 136-141.
86. Kirsch, J., Langosch, D., Prior, P., Littauer, U.Z., Schmitt, B. and Betz, H. (1991). The 93-kDa glycine receptor-associated protein binds to tubulin. J. Biol. Chem. 266, 22242-22245.
87. Koch, M., Kling, C., and Becker, C.M. (1996). Increased startle responses in mice carrying mutations of glycine receptor subunit genes. Neuroreport 7, 806-808.
88. 2+ permeability in both TM1 and TM2 of high affinity kainate receptor channels: diversity by RNA editing. Neuron 10, 491-500.
89. Kornau, H.C., Schenker, L.T., Kennedy, M.B., and Seeburg, P.H. (1995). Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269, 1737-1740.
90. Koshy, B.T., and Zoghbi, H.Y. (1997). The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol. 7, 927-942.
91. Kreusch, A., Pfaffinger, P.J., Stevens, C.F., and Choe, S. (1998). Crystal structure of the tetramerization domain of Shaker potassium channel. Nature, in press.
92. Krupp, J.J., Vissel, B., Heinemann, S.F., and Westbrook, G.L. (1998). N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron 20, 317-327.
93. Kuryatov, A., Laube, B., Betz, H., and Kuhse, J. (1994). Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins. Neuron 12, 1291-1300.
94. Kuusinen, A., Arvola, M., and Keinänen, K. (1995). Molecular dissection of the agonist binding site of an AMPA receptor. EMBO J. 14, 6327-6332.
95. Kyte, J., and Doolittle, R.F. (1982). A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132.
96. Langosch, D., Becker, C.M., and Betz, H. (1990). The inhibitory glycine receptor: a ligand-gated chloride channel of the central nervous system. Eur. J. Biochem. 194, 1-8.
97. Laube, B., Hirai, H., Sturgess, M., Betz, H., and Kuhse, J. (1997). Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2b subunit. Neuron 18, 493-503.
98. Leonoudakis, D., Gray, A.T., Winegar, B.D., Kindler, C.H., Harada, M., Taylor, D.M., Chavez, R.A., Forsayeth, J.R., and Yost, C.S. (1998). An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum. J. Neurosci. 18, 868-877.
99. Li, H., Lee, S., and Jap, B.K. (1997). Molecular design of aquaporin-1 water channel as revealed by electron crystallography. Nature Struct. Biol. 4, 263-265.
100. MacDonald, M.E., Novelletto, A., Lin, C., Tagle, D., Barnes, G., Bates, G., Taylor, S., Allitto, B., Altherr, M., Myers, R., et al. (1992). The Huntington's disease candidate region exhibits many different haplotypes. Nature Genet. 1, 99-103.
101. Malenka, R.C., and Nicoll, R.A. (1990). Intracellular signals and LTP. Semin. Neurosci. 2, 335-343.
102. Martin, J.B., and Gusella, J.F. (1986). Huntington's disease. Pathogenesis and management. N. Engl. J. Med. 315, 1267-1276.
103. Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., and Nakanishi, S. (1987). cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature 329, 836-838.
104. McHugh, T.J., Blum, K.I., Tsien, J.Z., Tonegawa, S., and Wilson, M.A. (1996). Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 87, 1339-1349.
105. Milani, N., Dalpra, L., del Prete, A., Zanini, R., and Larizza, L. (1996). A novel mutation (Gln266→His) in the alpha1 subunit of the inhibitory glycine receptor gene (GLRA1) in hereditary hyperekplexia. Am. J. Hum. Genet. 58, 420-422.
106. Milone, M., Wang, H.-L., Ohno, K., Fukudome, T., Pruitt, J.N., Bren, N., Sine, S.M., and Engel, A.G. (1997). Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J. Neurosci. 17, 5651-5665.
107. Mishina, M., Takai, T., Imoto, K., Noda, M., Takahashi, T., Numa, S., Methfessel, C., and Sakmann, B. (1986). Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321, 406-411.
108. Moon, I.S., Apperson, M.L., and Kennedy, M.B. (1994). The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. Proc. Natl. Acad. Sci. USA 91, 3954-3958.
109. Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., and Nakanishi, S. (1991). Molecular cloning and characterization of the rat NMDA receptor. Nature 354, 31-37.
110. Mulle, C., Sailer, A., Pérez-Otaño, I., Dickinson-Anson, H., Castillo, P.E., Bureau, I., Maron, C., Gage, F.H., Mann, J.R., Bettler, B., and Heinemann, S.F. (1998). Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature, in press.
111. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G., and Hayden, M.R. (1995). Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823.
112. A receptor determined by electron microscopic image analysis. J. Neurochem. 62, 815-818.
113. Nicoll, R.A., Kanes, J.A., and Malenka, R.C. (1988). The current excitement in long-term potentiation. Neuron 1, 97-103.
114. Noda, M., Takahashi, H., Tanabe, T., Toyosato, M., Furutani, Y., Hirose, T., Asai, M., Inayama, S., Miyata, T., and Numa, S. (1982). Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature 299, 793-797.
115. Noda, M., Takahashi, H., Tanabe, T., Toyosato, M., Kikyotani, S., Furutani, Y., Hirose, T., Takashima, H., Inayama, S., Miyata, T., and Numa, S. (1983). Structural homology of Torpedo californica acetylcholine receptor subunits. Nature 302, 528-532.
116. Noda, M., Shimizu, S., Tanabe, T., Takai, T., Kayano, T., Ikeda, T., Takahashi, H., Nakayama, H., Kanaoka, Y., Minamino, N., et al. (1984). Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence. Nature 312, 121-127.
117. Noda, M., Ikeda, T., Kayano, T., Suzuki, H., Takeshima, H., Kurasaki, M., Takahashi, H., and Numa, S. (1986). Existence of distinct sodium channel messenger RNAs in rat brain. Nature 320, 188-192.
118. Ohno, K., Hutchinson, D.O., Milone, M., Brengman, J.M., Bouzat, C., Sine, S.M., and Engel, A.G. (1995). Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ∈ subunit. Proc. Natl. Acad. Sci. USA 92, 758-762.
119. Ohno, K., Quiram, P.A., Milone, M., Wang, H.L., Harper, M.C., Pruitt, J.N., Brengman, J.M., Pao, L., Fischbeck, K.H., Crawford, T.O., et al. (1997). Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Hum. Mol. Genet. 6, 753-766.
120. Orr-Urteger, A., Göldner, F.M., Saeki, M., Lorenzo, I., Goldberg, L., De Biasi, M., Dani, J.A., Patrick, J.W., and Beaudet, A.L. (1997). Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17, 9165-9171.
121. Paas, Y., Eisenstein, M., Medevielle, F., Teichberg, V.I., and Devillers-Thiéry, A. (1996). Identification of the amino acid subsets accounting for the ligand binding specificity of a glutamate receptor. Neuron 17, 979-990.
122. Paschen, W., and Djuricic, B. (1994). Extent of RNA editing of glutamate receptor subunit GluR5 in different brain regions of the rat. Cell. Mol. Neurobiol. 14, 259-270.
123. Persichetti, F., Ambrose, C.M., Ge, P., McNeil, S.M., Srinidhi, J., Anderson, M.A., Jenkins, B., Barnes, G.T., Duyao, M.P., Kanaley, L., et al. (1995). Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol. Med. 1, 374-383.
124. Picciotto, M.R., Zoli, M., Rimondini, R., Léna, C., Marubio, L.M., Pich, E.M., Fuxe, K., and Changeux, J.-P. (1998). Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177.
125. Premkumar, L.S., and Auerbach, A. (1997). Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns. J. Gen. Physiol. 110, 485-502.
126. Raftery, M.A., Hunkapiller, M.W., Strader, C.D., and Hood, L.E. (1980). Acetylcholine receptor: complex of homologous subunits. Science 208, 1454-1456.
127. Rajendra, S., Lynch, J.W., Pierce, K.D., French, C.R., Barry, P.H., and Schofield, P.R. (1994). Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor. J. Biol. Chem. 269, 18739-18742.
128. Rajendra, S., Vandenberg, R.J., Pierce, K.D., Cunningham, A.M., French, P.W., Barry, P.H., and Schofield, P.R. (1995). The unique extracellular disulphide loop of the glycine receptor is a principal ligand-binding element. EMBO J. 14, 2987-2998.
129. Rassendren, F., Buell, G., Newbolt, A., North, R.A., and Surprenant, A. (1997). Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J. 16, 3446-3454.
130. Ratnam, M., Nguyen, D.L., Rivier, J., Sargent, P.B., and Lindstrom, J. (1986). Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydropathy profiles. Biochemistry 25, 2633-2643.
131. Rees, M.I., Andrew, M., Jawad, S., and Owen, M.J. (1994). Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha1 subunit of the inhibitory glycine receptor. Hum. Mol. Genet. 3, 2175-2179.
132. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., et al. (1993). Mutations in Cu/ Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
133. Ross, C.A. (1997). Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150.
134. Rubinsztein, D.C., Leggo, J., Chiano, M., Dodge, A., Norbury, G., Rosser, E., and Craufurd, D. (1997). Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc. Natl. Acad. Sci. USA 94, 3872-3876.
135. Ryan, S.G., Dixon, M.J., Nigro, M.A., Kelts, K.A., Markand, O.N., Terry, J.C., Shiang, R., Wasmuth, J.J., and O'Connell, P. (1992a). Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q. Am. J. Hum. Genet. 51, 1334-1343.
136. Ryan, S.G., Sherman, S.L., Terry, J.C., Sparkes, R.S., Torres, M.C., and Mackey, R.W. (1992b). Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. Ann. Neurol. 31, 663-668.
137. Ryan, S.G., Buckwalter, M.S., Lynch, J.W., Handford, C.A., Segura, L., Shiang, R., Wasmuth, J.J., Camper, S.A., Schofield, P., and O'Connell, P. (1994). A missense mutation in the gene encoding the alpha1 subunit of the inhibitory glycine receptor in the spasmodic mouse. Nature Genet. 7, 131-135.
138. Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G.P., Davies, S.W., Lehrach, H., and Wanker, E.E. (1997). Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.
139. Schmieden, V., Kuhse, J., and Betz, H. (1992). Agonist pharmacology of neonatal and adult glycine receptor α-subunits - identification of amino-acid residues involved in taurine activation. EMBO J. 11, 2025-2032.
140. Schoepfer, R., Conroy, W.G., Whiting, P., Gore, M., and Linstrom, J. (1990). Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5, 35-48.
141. Schwalbe, R.A., Blanchi, L., and Brown, A.M. (1997). Mapping the kidney potassium channel ROMK1. J. Biol. Chem. 272, 25217-25223.
142. Scotland, P.B., Colledge, M., Melnikova, I., Dai, Z., and Froehner, S.C. (1993). Clustering of the acetylcholine receptor by the 43-kd protein: involvement of the zinc finger domain. J. Cell Biol. 123, 719-728.
143. Seeburg, P.H. (1993). The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16, 359-365.
144. Seri, M., Bolino, A., Galietta, L.J., Lerone, M., Silengo, M., and Romeo, G. (1997). Startle disease in an Italian family by mutation (K276E): the alpha-subunit of the inhibiting glycine receptor. Hum. Mut. 9, 185-187.
145. Sharp, A.H., and Ross, C.A. (1996). Neurobiology of Huntington's disease. Neurobiol. Dis. 3, 3-15.
146. Sheng, M. (1996). PDZs and receptor/channel clustering: rounding up the latest suspects. Neuron 17, 575-578.
147. Shiang, R., Ryan, S.G., Zhu, Y.Z., Hahn, A.F., O'Connel, P., and Wasmuth, J.J. (1993). Mutations in the alpha1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genet. 5, 351-358.
148. Shiang, R., Ryan, S.G., Zhu, Y.Z., Fielder, T.J., Allen, R.J., Fryer, A., Yamashita, S., O'Connell, P., and Wasmuth, J.J. (1995). Mutational analysis of familial and sporadic hyperekplexia. Ann. Neurol. 38, 85-91.
149. Sine, S.M., Ohno, K., Bouzat, C., Auerbach, A., Milone, M., Pruitt, J.N., and Engel, A.G. (1995). Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15, 229-239.
150. Singh, N.A., Charlier, C., Stauffer, D., DuPont, B.R., Leach, R.J., Melis, R., Ronen, G.M., Bjerre, I., Quattlebaum, T., Murphy, J.V., et al. (1998). A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nature Genet. 18, 25-29.
151. Sommer, B., Köhler, M., Sprengel, R., and Seeburg, P.H. (1991). RNA editing in the brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11-19.
152. Sprengel, R., and Seeburg, P.H. (1995). Ionotropic glutamate receptors. In Ligand- and Voltage-Gated Ion Channels, A. R. North, ed. (Boca Raton, FL: CRC Press), pp. 213-263.
153. Sprengel, R., Suchanek, B., Aminco, C., Brusa, R., Burnashev, N., Rozov, A., Hvalby, Ø., Jensen, V., Paulsen, O., Andersen, P., et al. (1998). Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell 92, 279-289.
154. Steinlein, O.K., Mulley, J.C., Propping, P., Wallace, R.H., Phillips, H.A., Sutherland, G.R., Scheffer, I.E., and Berkovic, S.F. (1995). A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genet. 11, 201-203.
155. Steinlein, O.K., Magnusson, A., Stoodt, J., Bertrand, S., Weiland, S., Berkovic, S.F., Nakken, K.O., Propping, P., and Bertrand, D. (1997). An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6, 943-947.
156. Stern-Bach, Y., Bettler, B., Hartley, M., Sheppard, P.O., O'Hara, P.J., and Heinemann, S.F. (1994). Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron 13, 1345-1357.
157. Swanson, G.T., Gereau, R.W., IV, Green, T., and Heinemann, S.F. (1997). Identification of amino acid residues that control functional behavior in GluR5 and GluR6 kainate receptors. Neuron 19, 913-926.
158. + channels in vivo. J. Neurosci. 17, 152-159.
159. Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E.C., and Mandel, J.L. (1995a). Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10, 104-110.
160. Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Saudou, F., Weber, C., David, G., Tora, L., et al. (1995b). Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378, 403-406.
161. Tsien, J.Z., Huerta, P.T., and Tonegawa, S. (1996). The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87, 1327-1338.
162. Uchino, S., Sakimura, K., Nagahari, K., and Mishina, M. (1992). Mutations in a putative agonist binding region of the AMPA-selective glutamate receptor channel. FEBS Lett. 308, 253-257.
163. Unwin, N. (1993a). Neurotransmitter action: opening of ligand-gated ion channels. Cell 72/Neuron 10 (suppl.), 31-41.
164. Unwin, N. (1993b). Nicotinic acetylcholine receptor at 9Å resolution. J. Mol. Biol. 229, 1101-1124.
165. Verdoorn, T.A., Brunashev, N., Monyer, H., Seeburg, P.H., and Sakmann, B. (1991). Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252, 1715-1718.
166. Villarroel, A., Burnashev, N., and Sakmann, B. (1995). Dimensions of the narrow portion of a recombinant NMDA receptor channel. Biophys. J. 68, 866-875.
167. Villarroel, A., Regaldo, M.P., and Lerma, J. (1998). Glycine-independent NMDA receptor desensitization: localization of structural determinants. Neuron 20, 329-339.
168. Wang, H.L., Auerbach, A., Bren, N., Ohno, K., Engel, A.G., and Sine, S.M. (1997a). Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J. Gen. Physiol. 109, 757-766.
169. i-protein in cortical neurons. Nature 389, 502-504.
170. West, A.P., Bjorkman, P.J., Dougherty, D.A., and Lester, H.A. (1997). Expression and circular dichroism studies of the extracellular domain of the α subunit of the nicotinic acetylcholine receptor. J. Biol. Chem. 272, 25468-25473.
171. White, J.K., Auerbach, W., Duyao, M.P., Vonsattel, J.P., Gusella, J.F., Joyner, A.L., and MacDonald, M.E. (1997). Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet. 17, 404-410.
172. Wingrove, P.B., Thompson, S.A., Wafford, K.A., and Whiting, P.J. (1997). Key amino acids in the γ subunit of the γ-aminobutyric acid(A) receptor that determine ligand binding and modulation at the benzodiazepine site. Mol. Pharmacol. 52, 874-881.
173. Wo, Z.G., and Oswald, R.E. (1994). Transmembrane topology of two kainate receptor subunits revealed by N-glycosylation. Proc. Natl. Acad. Sci. USA 91, 7154-7158.
174. Yang, J., Jan, Y.N., and Jan, L.Y. (1995). Determination of the subunit stoichiometry of an inwardly rectifying potassium channel. Neuron 15, 1441-1447.
175. Zeitlin, S., Liu, J.P., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1995). Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11, 155-163.
176. Zuo, J., De Jager, P.L., Takahashi, K.A., Jiang, W., Linden, D.J., and Heintz, N. (1997). Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature 388, 769-773.